Authors:
MASIMIREMBWA CM
DANDARA C
SOMMERS DK
SNYMAN JR
HASLER JA
Citation: Cm. Masimirembwa et al., GENETIC-POLYMORPHISM OF CYTOCHROME P4501A1, MICROSOMAL EPOXIDE HYDROLASE, AND GLUTATHIONE S-TRANSFERASES M1 AND T1 IN ZIMBABWEANS AND VENDAOF SOUTHERN AFRICA, Pharmacogenetics, 8(1), 1998, pp. 83-85
Citation: Cm. Masimirembwa et Ja. Hasler, GENETIC-POLYMORPHISM OF DRUG-METABOLIZING-ENZYMES IN AFRICAN POPULATIONS - IMPLICATIONS FOR THE USE OF NEUROLEPTICS AND ANTIDEPRESSANTS, Brain research bulletin, 44(5), 1997, pp. 561-571
Authors:
MUKANGANYAMA S
MASIMIREMBWA CM
NAIK YS
HASLER JA
Citation: S. Mukanganyama et al., PHENOTYPING OF THE GLUTATHIONE-S-TRANSFERASE-M1 POLYMORPHISM IN ZIMBABWEANS AND THE EFFECTS OF CHLOROQUINE ON BLOOD GLUTATHIONE-S-TRANSFERASE-M1 AND GLUTATHIONE-S-TRANSFERASE-A, Clinica chimica acta, 265(2), 1997, pp. 145-155
Authors:
MASIMIREMBWA CM
GUSTAFSSON LL
DAHL ML
ABDI YA
HASLER JA
Citation: Cm. Masimirembwa et al., LACK OF EFFECT OF CHLOROQUINE ON THE DEBRISOQUINE (CYP2D6) AND S-MEPHENYTOIN (CYP2C19) HYDROXYLATION PHENOTYPES, British journal of clinical pharmacology, 41(4), 1996, pp. 344-346
Citation: Cm. Masimirembwa et al., INHIBITORY EFFECTS OF ANTIPARASITIC DRUGS ON CYTOCHROME-P450 2D6, European Journal of Clinical Pharmacology, 48(1), 1995, pp. 35-38
Authors:
MASIMIREMBWA CM
BEKE M
HASLER JA
TANG BK
KALOW W
Citation: Cm. Masimirembwa et al., LOW CYP1A2 ACTIVITY IN RURAL SHONA CHILDREN OF ZIMBABWE, Clinical pharmacology and therapeutics, 57(1), 1995, pp. 25-31
Citation: Cm. Masimirembwa et al., THE EFFECT OF CHLOROQUINE ON THE PHARMACOKINETICS AND METABOLISM OF PRAZIQUANTEL IN RATS AND IN HUMANS, Biopharmaceutics & drug disposition, 15(1), 1994, pp. 33-43
Citation: Cm. Masimirembwa et Ja. Hasler, CHARACTERIZATION OF PRAZIQUANTEL METABOLISM BY RAT-LIVER MICROSOMES USING CYTOCHROME-P450 INHIBITORS, Biochemical pharmacology, 48(9), 1994, pp. 1779-1783
Citation: Cm. Masimirembwa et al., EFFECTS OF PHENOBARBITAL AND 3-METHYLCHOLANTHRENE PRETREATMENT ON THEPHARMACOKINETICS OF PRAZIQUANTEL IN RATS, European journal of drug metabolism and pharmacokinetics, 18(3), 1993, pp. 261-264